--- title: "Muzero Acquisition | 10-K: FY2025 Revenue: USD 0" type: "News" locale: "zh-CN" url: "https://longbridge.com/zh-CN/news/280844997.md" datetime: "2026-03-27T20:47:20.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/280844997.md) - [en](https://longbridge.com/en/news/280844997.md) - [zh-HK](https://longbridge.com/zh-HK/news/280844997.md) --- > 支持的语言: [English](https://longbridge.com/en/news/280844997.md) | [繁體中文](https://longbridge.com/zh-HK/news/280844997.md) # Muzero Acquisition | 10-K: FY2025 Revenue: USD 0 Revenue: As of FY2025, the actual value is USD 0. EPS: As of FY2025, the actual value is USD -0.01. EBIT: As of FY2025, the actual value is USD -49.54 K. #### Overview Muzero Acquisition Corp is a blank check company that has not generated any operating revenues to date and does not expect to until the completion of its initial Business Combination. #### Operational Metrics For the period from October 10, 2025 (inception) through December 31, 2025, Muzero Acquisition Corp reported a net loss of - $49,541, primarily consisting of general and administrative costs. General and administrative expenses for this period also totaled $49,541. #### Cash Flow Net cash used in operating activities was - $39,881 for the period from October 10, 2025 (inception) through December 31, 2025. Net cash provided by financing activities was $39,950, resulting in a net change in cash of $69. As of December 31, 2025, the company had $69 in cash. Following the closing of the Initial Public Offering on February 2, 2026, the company had cash held outside of the Trust Account of approximately $1,349,169. #### Key Financial Indicators - **IPO Gross Proceeds**: Muzero Acquisition Corp generated gross proceeds of $201,250,000 from its Initial Public Offering on February 2, 2026. - **Private Placement Gross Proceeds**: The private sale of 486,875 Private Placement Units generated gross proceeds of $4,868,750. - **Trust Account Funds**: A total of $201,250,000 from the net proceeds of the IPO and Private Placement was placed in a Trust Account. - **IPO Fees**: Total IPO fees amounted to $10,649,942, including a $3,521,875 cash underwriting fee (net of $503,125 reimbursement), a $7,043,750 Deferred Fee, and $587,442 in other offering costs. - **IPO Promissory Note Repayment**: A loan of $230,000 under the IPO Promissory Note was fully repaid upon the consummation of the IPO on February 2, 2026. - **Advances from Related Party**: As of March 27, 2026, the aggregate amount outstanding from advances from a related party was $45. - **Working Capital Deficit**: As of December 31, 2025, the company had a working capital deficit of - $219,622. - **Administrative Services Agreement**: The company committed to reimbursing an affiliate of its Sponsor $15,000 per month for office space, utilities, and administrative support, commencing January 30, 2026. #### Outlook / Guidance Muzero Acquisition Corp is an early-stage blank check company focused on completing a Business Combination, specifically targeting technology-enabled businesses. The company has until February 2, 2028, to consummate its initial Business Combination, with provisions for extension or liquidation if unsuccessful. While anticipating increased expenses as a public company, management believes it has sufficient funds for current operations but acknowledges additional financing may be required for a Business Combination or if existing funds are depleted. ### 相关股票 - [Muzero Acquisition (MUZE.US)](https://longbridge.com/zh-CN/quote/MUZE.US.md) ## 相关资讯与研究 - [TK Elevator keeps IPO option on the table](https://longbridge.com/zh-CN/news/281135641.md) - [SpaceX Eyes IPO Valuation of Over $2 Trillion](https://longbridge.com/zh-CN/news/281578787.md) - [KPET Ultra Paceline Corporation Announces Pricing of Initial Public Offering | KPET Stock News](https://longbridge.com/zh-CN/news/281076881.md) - [OpenAI raises $122bn, edging closer to an IPO](https://longbridge.com/zh-CN/news/281242932.md) - [SpaceX Taps at Least 21 Banks for Planned IPO](https://longbridge.com/zh-CN/news/281336339.md)